Abstract
In view of the only modest functional and anatomical improvements achieved by bone marrow-derived cell transplantation in patients with heart disease, the question was addressed whether the intracoronary, transcoronary–venous, and intramyocardial delivery routes are adequate. It is hypothesized that an intrapericardial delivery of stem cells or activators of resident cardiac stem cells increases therapeutic benefits. From such an intrapericardial depot, cells or modulating factors, such as thymosin β4 or Ac-SDKP, are expected to reach the myocardium with sustained kinetics. Novel tools which provide access to the pericardial space even in the absence of pericardial effusion are, therefore, described. When the pericardium becomes attached to the suction head (monitored by an increase in negative pressure), the pericardium is lifted from the epicardium (“AttachLifter”). The opening of the suction head (“Attacher”) is narrowed by flexible clamps which grab the tissue and improve the vacuum seal in the case of uneven tissue. A ridge, i.e.,“needle guidance”, on the suction head excludes injury to the epicardium, whereby the pericardium is punctured by a needle which resides outside the suction head. A fiberscope can be used to inspect the pericardium prior to puncture. Based on these procedures, the role of the pericardial space and the presence of pericardial effusion in cardiac regeneration can be assessed.
Zusammenfassung
Angesichts der nur moderaten funktionellen und anatomischen Verbesserungen durch eine Stammzelltransplantation bei Herzerkrankungen stellt sich die Frage, ob die intrakoronaren, transkoronar-venösen und intramyokardialen Applikationswege ausreichen. Wir postulieren, dass eine intraperikardiale Applikation von Stammzellen bzw. Aktivatoren der residenten kardialen Stammzellen den therapeutischen Nutzen erhöht. Aus dem intraperikardialen Depot erreichen Zellen bzw. modulierende Faktoren (z. B. Thymosin β4, AC-SDKP) das Myokard in einer protrahierten Kinetik. Daher werden neue Instrumente beschrieben, die den Zugang in den Herzbeutel auch in Abwesenheit eines Perikardergusses ermöglichen. Das Perikard wird an den Ansaugkopf eines solchen Instruments (AttachLifter) angeheftet, die Anheftung wird überwacht durch einen Anstieg des Unterdrucks. Dabei wird Perikard vom Epikard angehoben („Lifter“), die Öffnung des Ansaugkopfes („Attacher“) wird durch flexible Klemmen eingeengt, die das Gewebe festhalten und einen Vakuumverlust bei unebenem Gewebe verhindern. Eine geeignete Nadelführung am Ansaugkopf verhindert eine Verletzung des Epikards während der Perikardpunktion (Nadel befindet sich außerhalb des Ansaugkopfes). Zur Beurteilung der Perikardoberfläche kann vor der Punktion eine Fiberglasoptik (Perikardioskop) eingesetzt werden. Basierend auf diesen Verfahren kann die Beschaffenheit des Perikards mit oder ohne Perikarderguss bei der kardialen Regeneration bewertet werden.
Similar content being viewed by others
References
Abdel-Latif A, Bolli R, Tleyjeh IM et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989–997
Alter P, Grimm W, Vollrath A et al (2006) Heart rate variability in patients with cardiac hypertrophy–relation to left ventricular mass and etiology. Am Heart J 151:829–836
Alter P, Rupp H, Maisch B (2006) Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy–relation to inflammation and cardiac function. Biochem Biophys Res Commun 339:180–187
Alter P, Rupp H, Maisch B (2008) Assessment and relevance of ventricular wall stress in heart failure. Eur Heart J 29:2316
Alter P, Rupp H, Rominger MB et al (2009) Depression of heart rate variability in patients with increased ventricular wall stress. Pacing Clin Electrophysiol 32(Suppl 1):S26–S31
Alter P, Rupp H, Rominger MB et al (2008) A new methodological approach to assess cardiac work by pressure-volume and stress-length relations in patients with aortic valve stenosis and dilated cardiomyopathy. Pflugers Arch 455:627–636
Alter P, Rupp H, Rominger MB et al (2008) B-type natriuretic peptide and wall stress in dilated human heart. Mol Cell Biochem 314:179–191
Alter P, Rupp H, Rominger MB et al (2007) Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy. Can J Physiol Pharmacol 85:790–799
Baek SH, Hrabie JA, Keefer LK et al (2002) Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 105:2779–2784
Benetti F, Penherrera E, Maldonado T et al (2010) Direct myocardial implantation of human fetal stem cells in heart failure patients: long-term results. Heart Surg Forum 13:E31–E35
Bittner RE, Schofer C, Weipoltshammer K et al (1999) Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 199:391–396
Boulanger CM, Ezan E, Masse F et al (1998) The hemoregulatory peptide N-acetyl-ser-asp-lys-pro impairs angiotensin I-induced contractions in rat aorta. Eur J Pharmacol 363:153–156
Branco E, Fioretto ET, Cabral R et al (2009) Myocardial homing after intrapericardial infusion of bone marrow mononuclear cells. Arq Bras Cardiol 93:e50–e53
Carde P (1994) Inhibitors of hematopoiesis: from physiology to therapy. Bull Acad Natl Med 178:793–803
Franz MR, Cima R, Wang D et al (1992) Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 86:968–978
Hermans JJ, Essen H van, Struijker-Boudier HA et al (2002) Pharmacokinetic advantage of intrapericardially applied substances in the rat. J Pharmacol Exp Ther 301:672–678
Hosoda T, Kajstura J, Leri A, Anversa P (2010) Mechanisms of myocardial regeneration. Circ J 74:13–17
Ichim TE, Solano F, Lara F et al (2010) Combination stem cell therapy for heart failure. Int Arch Med 3:5
Jackson JD, Yan Y, Ewel C, Talmadge JE (1996) Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures. Exp Hematol 24:475–481
Kelly D, Mackenzie L, Hunter P et al (2006) Gene expression of stretch-activated channels and mechanoelectric feedback in the heart. Clin Exp Pharmacol Physiol 33:642–648
Kolettis TM, Kazakos N, Katsouras CS et al (2005) Intrapericardial drug delivery: pharmacologic properties and long-term safety in swine. Int J Cardiol 99:415–421
Kollar K, Cook MM, Atkinson K, Brooke G (2009) Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol 2009:904682
Limana F, Bertolami C, Mangoni A et al (2010) Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol 48:609–618
Limana F, Zacheo A, Mocini D et al (2007) Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res 101:1255–1265
Macris MP, Igo SR (1999) Minimally invasive access of the normal pericardium: initial clinical experience with a novel device. Clin Cardiol 22:I36–I39
Maisch B, Drude L (1992) Pericardioscopy—a new window to the heart in inflammatory heart diseases. Herz 17:71–78
Maisch B, Ristic A, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone. The way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23:1503–1508
Maisch B, Ristic A, Pankuweit S et al (2002) Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23:1625–1631
Maisch B, Ristic A, Seferovic PM, Tsang T (2010) Interventional pericardiology. Springer, Berlin
Maisch B, Ristic AD, Rupp H, Spodick DH (2001) Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88:1323–1326
Maisch B, Ristic AD, Seferovic PM, Spodick DH (2000) Intrapericardial treatment of autoreactive myocarditis with triamcinolon. Successful administration in patients with minimal pericardial effusion. Herz 25:781–786
Maisch B, Seferovic PM, Ristic AD et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25:587–610
Malouf NN, Coleman WB, Grisham JW et al (2001) Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol 158:1929–1935
Manner J (1992) The development of pericardial villi in the chick embryo. Anat Embryol (Berl) 186:379–385
Nagashima H, Kawashiro-Hirata N, Imamura K et al (2000) Congestive heart failure after peripheral blood stem cell transplantation: role of cytokines. Jpn Circ J 64:382–384
Orlic D, Kajstura J, Chimenti S et al (2001) Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 938:221–229; discussion 229–230
Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705
Orlic D, Kajstura J, Chimenti S et al (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98:10344–10349
Pankuweit S, Wadlich A, Meyer E et al (2000) Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 25:748–754
Peng H, Carretero OA, Peterson EL, Rhaleb NE (2010) Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts. Am J Physiol Heart Circ Physiol 298:H1357–H1364
Peng H, Carretero OA, Raij L et al (2001) Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension 37:794–800
Platzbecker U, Klingel K, Thiede C et al (2001) Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplant 27:107–109
Popescu LM, Gherghiceanu M, Manole CG, Faussone-Pellegrini MS (2009) Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med 13:866–886
Rasoul S, Carretero OA, Peng H et al (2004) Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension. J Hypertens 22:593–603
Rhaleb NE, Peng H, Yang XP et al (2001) Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Circulation 103:3136–3141
Rose M, Lee FA, Gollerkeri A et al (2000) The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function. Bone Marrow Transplant 26:133–139
Rossdeutsch A, Smart N, Riley PR (2008) Thymosin beta4 and Ac-SDKP: tools to mend a broken heart. J Mol Med 86:29–35
Rupp H, Alter P, Maisch B (2002) Stem cells for the failing heart—does ACE inhibition interfere? J Clin Res 8:10–13
Rupp H, Rupp TP, Alter P, Maisch B (2006) Acute heart failure–basic pathomechanism and new drug targets. Herz 31:727–735
Rupp H, Rupp TP, Alter P, Maisch B (2010) Inverse shift in serum polyunsaturated and monounsaturated fatty acids is associated with adverse dilatation of the heart. Heart 96:595–598
Rupp H, Rupp TP, Maisch B (2005) Fatty acid oxidation inhibition with PPARalpha activation (FOXIB/PPARalpha) for normalizing gene expression in heart failure? Cardiovasc Res 66:423–426
Seferovic PM, Ristic AD, Maksimovic R et al (2000) Flexible percutaneous pericardioscopy: inherent drawbacks and recent advances. Herz 25:741–747
Smart N, Riley PR (2009) Derivation of epicardium-derived progenitor cells (EPDCs) from adult epicardium. Curr Protoc Stem Cell Biol Chapter 2:Unit2C
Smart N, Risebro CA, Melville AA et al (2007) Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Ann N Y Acad Sci 1112:171–188
Steele A, Jones OY, Gok F et al (2005) Stem-like cells traffic from heart ex vivo, expand in vitro, and can be transplanted in vivo. J Heart Lung Transplant 24:1930–1939
Strauer BE, Brehm M, Zeus T et al (2001) Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr 126:932–938
Strauer BE, Yousef M, Schannwell CM (2010) The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heart failure: the STAR-heart study. Eur J Heart Fail 12:721–729
Tomita S, Li RK, Weisel RD et al (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247–II256
Urbanek K, Cesselli D, Rota M et al (2006) Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 103:9226–9231
Wang Z, Taylor LK, Denney WD, Hansen DE (1994) Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation 90:2022–2031
Watanabe H, Murakami M, Ohba T et al (2008) TRP channel and cardiovascular disease. Pharmacol Ther 118:337–351
Weeke-Klimp A, Bax NA, Bellu AR et al (2010) Epicardium-derived cells enhance proliferation, cellular maturation and alignment of cardiomyocytes. J Mol Cell Cardiol 49:606–616
Winter EM, Gittenberger-de Groot AC (2007) Epicardium-derived cells in cardiogenesis and cardiac regeneration. Cell Mol Life Sci 64:692–703
Xiao YF, Sigg DC, Ujhelyi MR et al (2008) Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am J Physiol Heart Circ Physiol 294:H2212–H2218
Acknowledgments
The study was supported by the Marburg Cardiac Promotion Society.
Conflict of interest
The corresponding author states that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rupp, H., Rupp, T., Alter, P. et al. Intrapericardial procedures for cardiac regeneration by stem cells. Herz 35, 458–466 (2010). https://doi.org/10.1007/s00059-010-3382-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-010-3382-7